355 related articles for article (PubMed ID: 26772755)
1. DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression.
Borghesan M; Fusilli C; Rappa F; Panebianco C; Rizzo G; Oben JA; Mazzoccoli G; Faulkes C; Pata I; Agodi A; Rezaee F; Minogue S; Warren A; Peterson A; Sedivy JM; Douet J; Buschbeck M; Cappello F; Mazza T; Pazienza V; Vinciguerra M
Cancer Res; 2016 Feb; 76(3):594-606. PubMed ID: 26772755
[TBL] [Abstract][Full Text] [Related]
2. MacroH2A1 isoforms are associated with epigenetic markers for activation of lipogenic genes in fat-induced steatosis.
Podrini C; Koffas A; Chokshi S; Vinciguerra M; Lelliott CJ; White JK; Adissu HA; Williams R; Greco A
FASEB J; 2015 May; 29(5):1676-87. PubMed ID: 25526730
[TBL] [Abstract][Full Text] [Related]
3. Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinoma.
Rappa F; Greco A; Podrini C; Cappello F; Foti M; Bourgoin L; Peyrou M; Marino A; Scibetta N; Williams R; Mazzoccoli G; Federici M; Pazienza V; Vinciguerra M
PLoS One; 2013; 8(1):e54458. PubMed ID: 23372727
[TBL] [Abstract][Full Text] [Related]
4. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.
Zhang C; Li H; Wang Y; Liu W; Zhang Q; Zhang T; Zhang X; Han B; Zhou G
J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009
[TBL] [Abstract][Full Text] [Related]
7. Metabolic perturbation of epigenome by inhibiting S-adenosylhomocysteine hydrolase elicits senescence through DNA damage response in hepatoma cells.
Wu G; Wang N; Luo Y; Zhang Y; Wang P; Zhu Z; Gao Y; Du Z; Yang B
Tumour Biol; 2017 May; 39(5):1010428317699117. PubMed ID: 28459194
[TBL] [Abstract][Full Text] [Related]
8. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
Zhao R; Wang N; Huang H; Ma W; Yan Q
Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
[TBL] [Abstract][Full Text] [Related]
9. Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma.
Lo Re O; Fusilli C; Rappa F; Van Haele M; Douet J; Pindjakova J; Rocha SW; Pata I; Valčíková B; Uldrijan S; Yeung RS; Peixoto CA; Roskams T; Buschbeck M; Mazza T; Vinciguerra M
Hepatology; 2018 Feb; 67(2):636-650. PubMed ID: 28913935
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma.
Wong CM; Ng YL; Lee JM; Wong CC; Cheung OF; Chan CY; Tung EK; Ching YP; Ng IO
Hepatology; 2007 May; 45(5):1129-38. PubMed ID: 17464989
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
12. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells.
Chan DW; Lee JM; Chan PC; Ng IO
Int J Cancer; 2008 Sep; 123(5):1043-52. PubMed ID: 18553387
[TBL] [Abstract][Full Text] [Related]
13. MacroH2A1 and ATM Play Opposing Roles in Paracrine Senescence and the Senescence-Associated Secretory Phenotype.
Chen H; Ruiz PD; McKimpson WM; Novikov L; Kitsis RN; Gamble MJ
Mol Cell; 2015 Sep; 59(5):719-31. PubMed ID: 26300260
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic combination therapy as a tumor-selective treatment approach for hepatocellular carcinoma.
Venturelli S; Armeanu S; Pathil A; Hsieh CJ; Weiss TS; Vonthein R; Wehrmann M; Gregor M; Lauer UM; Bitzer M
Cancer; 2007 May; 109(10):2132-41. PubMed ID: 17407132
[TBL] [Abstract][Full Text] [Related]
15. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma.
Jueliger S; Lyons J; Cannito S; Pata I; Pata P; Shkolnaya M; Lo Re O; Peyrou M; Villarroya F; Pazienza V; Rappa F; Cappello F; Azab M; Taverna P; Vinciguerra M
Epigenetics; 2016 Oct; 11(10):709-720. PubMed ID: 27646854
[TBL] [Abstract][Full Text] [Related]
18. Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4
Lo Re O; Mazza T; Giallongo S; Sanna P; Rappa F; Vinh Luong T; Li Volti G; Drovakova A; Roskams T; Van Haele M; Tsochatzis E; Vinciguerra M
Theranostics; 2020; 10(2):910-924. PubMed ID: 31903159
[No Abstract] [Full Text] [Related]
19. Histone MacroH2A1: A Chromatin Point of Intersection between Fasting, Senescence and Cellular Regeneration.
Lo Re O; Vinciguerra M
Genes (Basel); 2017 Dec; 8(12):. PubMed ID: 29206173
[TBL] [Abstract][Full Text] [Related]
20. Histone variant macroH2A1 rewires carbohydrate and lipid metabolism of hepatocellular carcinoma cells towards cancer stem cells.
Lo Re O; Douet J; Buschbeck M; Fusilli C; Pazienza V; Panebianco C; Castracani CC; Mazza T; Li Volti G; Vinciguerra M
Epigenetics; 2018; 13(8):829-845. PubMed ID: 30165787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]